ClinicalTrials.gg
Sign In

Prostatic Hyperplasia clinical trials

The registry lists 827 studies for Prostatic Hyperplasia across more than 10 countries. 179 are recruiting or about to start. 678 of them are mainly about Prostatic Hyperplasia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

ClinicalTrials.gov finds 886 studies for Prostatic Hyperplasia. How that becomes 826 here

This page counts the studies the registry files under Prostatic Hyperplasia, and those it files under no condition that list Prostatic Hyperplasiathemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 886Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −4List Prostatic Hyperplasia as a condition, but the registry did not file them under itMost often written as “Prostatic Hyperplasia of the Medial Lobe” (1), “Benign Prostatic Hyperplasia With Outflow Obstruction” (1), and “Benign Prostatic Hyperplasia Postoperative Pain” (1). The registry filed them under other conditions only, most often Lower Urinary Tract Symptoms (3) and Urinary Retention (1).
  3. −56Match it another way41 name it in the title, 1 in a keyword, and 14 by a synonym or other text the search reads.
  4. 826The count on this page16 of them list Prostatic Hyperplasia in their own words; the registry filed them under no condition.

Get an email when these change. Save the Prostatic Hyperplasia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
455
Recruiting
102
Status unknown
91
Not yet recruiting
73
Terminated
40
Active, not recruiting
38

Phase

Phase 4
97
Phase 3
90
Phase 2
77
Phase 1
63
Early Phase 1
8

Where

United States
187
Egypt
79
Korea, Republic of
61
France
59
Canada
53
China
53

Who runs them

GlaxoSmithKline (43) · Boehringer Ingelheim (18) · Eli Lilly and Company (17) · Mansoura University (16) · Ain Shams University (14) · Samsung Medical Center (12) · Beni-Suef University (11) · Boston Scientific Corporation (11)

What is being tested here

Drugs under test in Prostatic Hyperplasia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Tamsulosin81148
Silodosin4418
Tranexamic Acid304
Tadalafil21126
AD-1161203
Dutasteride1427
Finasteride1510
RT-310103
Lorazepam111
Coenzyme Q10101

Drug classes tested here 5-alpha reductase inhibitors 2 open · PDE5 inhibitors 2 open · Antimuscarinics 12

Coming up

12phase 3 studies under way
73studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 102 Prostatic Hyperplasia studies recruiting now, 70 (69%) set no upper age limit and 4 (4%) stop at 75 or younger. 7 (7%) take children under 18. 0 (0%) are for women only and 99 (97%) for men only; 7 (7%) take healthy volunteers.

Recruiting studies that take each age, of 102
AgeWomenMen
100 (0%)5 (5%)
181 (1%)41 (40%)
302 (2%)44 (43%)
402 (2%)56 (55%)
503 (3%)100 (98%)
653 (3%)101 (99%)
753 (3%)100 (98%)
853 (3%)85 (83%)

Across all 827 studies, recruiting or not: 9% stop at 75 or younger and 5% at 65; 8% take children; 0% are for women only and 96% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Prostatic Hyperplasia studies take

Of 34 phase 1 interventional studies under Prostatic Hyperplasia, half reached primary completion within 3 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 13 mo1–6 · 34 studies3 mo1–4 · 26 studies—
Phase 232 mo13–76 · 17 studies——
Phase 328 mo19–50 · 17 studies——
Phase 423 mo10–26 · 28 studies——
Interventional, no phase26 mo14–48 · 203 studies30 mo10–50 · 51 studies25 mo14–48 · 152 studies
Observational25 mo12–50 · 74 studies—33 mo10–50 · 59 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting4

Newly registered8

Show 3 more

Studies

Recruiting first, then most recently updated. Showing 50 of 827. Browse all 827 → or search them.